SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001395064-21-000203
Filing Date
2021-10-15
Accepted
2021-10-15 18:40:19
Documents
1
Period of Report
2021-10-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_163433760471855.html 4  
1 FORM 4 wf-form4_163433760471855.xml 4 7757
  Complete submission text file 0001395064-21-000203.txt   9936
Mailing Address 125 BINNEY STREET CAMBRIDGE MA 02142
Business Address 125 BINNEY STREET CAMBRIDGE MA 02142 6174940400
ARIAD PHARMACEUTICALS INC (Reporting) CIK: 0000884731 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40869 | Film No.: 211326997
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Reporting) CIK: 0001395064 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40869 | Film No.: 211326998
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 245 MAIN STREET CAMBRIDGE MA 02142
Business Address 245 MAIN STREET CAMBRIDGE MA 02142 (857) 400-9491
Theseus Pharmaceuticals, Inc. (Issuer) CIK: 0001745020 (see all company filings)

IRS No.: 830712806 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences